» Articles » PMID: 15307455

Diagnostic Accuracy of the American Diabetes Association Criteria in the Diagnosis of Glucose Intolerance Among High-risk Omani Subjects

Overview
Journal Ann Saudi Med
Specialty General Medicine
Date 2004 Aug 17
PMID 15307455
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Type 2 diabetes mellitus is highly prevalent in the rapidly growing Omani population. The American Diabetes Association (ADA) has recommended new criteria for Type 2 diabetes, but the new criteria have been challenged as inadequate. We measured the sensitivityand specificity of theADA criteria compared with World Health Organization (WHO) criteria for the diagnosis of abnormal glucose intolerance in Omani subjects.

Methods: Subjects not known to have diabetes were recruited from the Lipid and Endocrine Clinics at Sultan Qaboos University Hospital between 1999 and 2001. Fasting and 2-hour post-75g oral glucose tolerance test (OGTT) glucose levels were measured according to WHO criteria.

Results: 176 subjects were recruited for the study. WHO and the ADA criteria were in agreement for 104 out of 115 normal glucose tolerance (NGT), 4 out of 38 impaired glucose tolerance (IGT), and 14 out of 23 diabetic tolerance glucose (DGT) corresponding to a sensitivity of 90%, 10%, and 61% for NGT, IGT, and DGT, respectively. Compared with WHO criteria, the ADA criteria had 30% sensitivity and 90% specificity overall. Comparing fasting glucose cutoff values for the diagnosis of IGT, a cut-off of 5.9 mmol/L yielded the best diagnostic sensitivity and specificity compared to the 6.1 mmol/L recommended by the ADA criteria as determined by the receiver-operating characteristics (ROC), with an area under the curve of 0.677 vs. 0.387, respectively.

Conclusion: The ADA criteria had poor sensitivity in the detection of impaired glucose tolerance in high-risk Omani subjects compared with WHO criteria.

Citing Articles

Metabolic Effects of an Oral Glucose Tolerance Test Compared to the Mixed Meal Tolerance Tests: A Narrative Review.

Lages M, Barros R, Moreira P, Guarino M Nutrients. 2022; 14(10).

PMID: 35631171 PMC: 9147413. DOI: 10.3390/nu14102032.

References
1.
Liao D, Shofer J, Boyko E, McNeely M, Leonetti D, Kahn S . Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose. Diabetes Care. 2001; 24(1):39-44. DOI: 10.2337/diacare.24.1.39. View

2.
Songer T, Zimmet P . Epidemiology of type II diabetes: an international perspective. Pharmacoeconomics. 1994; 8 Suppl 1:1-11. DOI: 10.2165/00019053-199500081-00003. View

3.
Davies M, Muehlbayer S, Garrick P, McNally P . Potential impact of a change in the diagnostic criteria for diabetes mellitus on the prevalence of abnormal glucose tolerance in a local community at risk of diabetes: impact of new diagnostic criteria for diabetes mellitus. Diabet Med. 1999; 16(4):343-6. DOI: 10.1046/j.1464-5491.1999.00056.x. View

4.
Gimeno S, Ferreira S, Franco L, IUNES M . Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group. Diabetes Care. 1998; 21(11):1889-92. DOI: 10.2337/diacare.21.11.1889. View

5.
Asfour M, Lambourne A, Soliman A, Bold A, Mahtab H, King H . High prevalence of diabetes mellitus and impaired glucose tolerance in the Sultanate of Oman: results of the 1991 national survey. Diabet Med. 1995; 12(12):1122-5. DOI: 10.1111/j.1464-5491.1995.tb00431.x. View